This week the Food and Drug Administration (FDA) granted emergency use authorization for the first rapid home-based test for SARS-CoV-2. The test requires users to collect a nasal sample and swirl it in a vial of laboratory solution, which then plugs into a portable device. The test delivers results in 30 minutes. The manufacturer, Lucira, said it expects to charge $50 for the test and make it available nationwide by the spring. The company said its results matched those of laboratory-based tests 94% of the time. (AP News article, 11/18/20)
